BofA Securities issued a research report stating that ASMPT (00522) delivered weaker-than-expected Q3 results due to profit contraction and restructuring costs. However, the company's management provided positive guidance for Q4, projecting sales between US$470 million and US$530 million. At the midpoint, this represents a 7% quarter-on-quarter increase and a 14% year-on-year rise.

The bank expects ASMPT to achieve strong earnings growth next year, with EPS potentially more than doubling due to a low base in 2025. However, absolute revenue and profit levels are anticipated to remain at mid-cycle ranges. BofA Securities reiterated its "Neutral" rating on ASMPT while lowering the target price from HK$100 to HK$95.